MX1013
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 471029

CAS#: 582316-00-5

Description: MX1013 is a dipeptide pan-caspase inhibitor that inhibits caspase-1, caspase-3, and caspase-6, -7, -8, and -9.


Price and Availability

Size
Price

100mg
USD 550
Size
Price

250mg
USD 1050
Size
Price

1g
USD 2250

MX1013, purity > 96%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 471029
Name: MX1013
CAS#: 582316-00-5
Chemical Formula: C18H23FN2O6
Exact Mass: 382.154
Molecular Weight: 382.39
Elemental Analysis: C, 56.54; H, 6.06; F, 4.97; N, 7.33; O, 25.10


Synonym: MX1013, MX 1013, MX-1013

IUPAC/Chemical Name: 3-((S)-2-(((benzyloxy)carbonyl)amino)-3-methylbutanamido)-5-fluoro-4-oxopentanoic acid

InChi Key: LYBWGROBJJXCJJ-VYIIXAMBSA-N

InChi Code: InChI=1S/C18H23FN2O6/c1-11(2)16(17(25)20-13(8-15(23)24)14(22)9-19)21-18(26)27-10-12-6-4-3-5-7-12/h3-7,11,13,16H,8-10H2,1-2H3,(H,20,25)(H,21,26)(H,23,24)/t13?,16-/m0/s1

SMILES Code: O=C(CC(C(CF)=O)NC([C@H](C(C)C)NC(OCC1=CC=CC=C1)=O)=O)O


Technical Data

Appearance:
Solid powder

Purity:
>96% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>3 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
2934.99.90.01


References

1. Yang, W., Guastella, J., Huang, J.-C., et al. MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activity. Br. J. Pharmacol. 140(2), 402-412 (2003).